A study investigating the effect of Taspoglutide on gastric emptying

• Research type

  Research Study

• Full title

  A Randomized, double-blind, placebo controlled, parallel group study to investigate the effect of Taspoglutide on gastric emptying measured by a paracetamol test after single dose and multiple doses in patients with Type 2 diabetes.

• IRAS ID

  8614

• Sponsor organisation

  F.Hoffmann-La Roche LTD

• Eudract number

  2008-003575-47

• ISRCTN Number

  n.a

• Clinicaltrials.gov Identifier

  n.a

• Research summary

  The study aims to develop a potential new drug for Type 2 diabetes.This study is being carried out to investigate the effect the study drug (Taspoglutide (RO5073031) has on gastric emptying (the rate at which food/fluids pass through the stomach), blood glucose (sugar) levels, and kidney function following single and multiple doses of the study drug.The study will also look at how the study drug is taken up, metabolised and distributed through the body (pharmacokinetics).

• REC name

  East of England - Cambridge East Research Ethics Committee

• REC reference

  08/H0304/88

• Date of REC Opinion

  1 Dec 2008

• REC opinion

  Further Information Favourable Opinion